Chinese biotech firm Abbisko raises $123 million from Carlyle, Warburg
2 Min Read FILE PHOTO: The logo of the Carlyle Group is displayed at the companys office in Tokyo, Japan October 17, 2018. REUTERS/Issei Kato HONG KONG (Reuters) - Chinese biotech company Abbisko Therapeutics Co has raised $123 million from more than a dozen investors, including Carlyle Group and Warburg Pincus, in its latest funding round, the company said on Friday. Abbisko said in a news release that Carlyle led the latest fundraising with Warburg, OrbiMed, Lake Bleu Capital, and an unnamed ...
United States Warburg Pincus Kane Wu Himani Sarkar Thomson Reuters Trust Principles Greater Bay Area Homeland Development Fund
Source: reuters.com